UNIVERSITY OF NOTRE DAME
MimicMaker: an integrated platform for identifying relevant mimics of T cell antigens
MimicMaker: an integrated platform for identifying relevant mimics of T cell antigens is a funding opportunity from UNIVERSITY OF NOTRE DAME, up to 434500, closing April 30, 2028.
Apr 30, 2028
(639d left)Overview
SUMMARY Advances in immunology are revolutionizing medicine. The last 10-20 years have seen the rapid development of a range of transformative immunotherapies, with numerous others on the horizon, including new precision and personalized therapies for cancer and infectious disease. Advances in immunology are also…